journal article·2024-11-27Open access

Butterfly-Inspired Multiple Cross-Linked Dopamine–Metal–Phenol Bioprosthetic Valves with Enhanced Endothelialization and Anticalcification

Yuqing Zhang, Hai Hu, Yaoxi Zhu, Jie Xiao, Chenghao Li, Chen Qian, Xiaobo Yu, Jinping Zhao, Xing Chen, Jinping Liu, Jianliang Zhou

ACS Applied Materials & Interfaces· Volume 16· Issue 47

Abstract

Valve replacement is the most effective means of treating heart valve diseases, and transcatheter heart valve replacement (THVR) is the hottest field at present. However, the durability of the commercial bioprosthetic valves has always been the limiting factor restricting the development of interventional valve technology. The chronic inflammatory reaction, calcification, and difficulty in endothelialization after the implantation of a glutaraldehyde cross-linked porcine aortic valve or bovine pericardium often led to valve degeneration. Improving the biocompatibility of valve materials and inducing endothelialization to promote in situ regeneration can extend the service life of valve materials. Herein, inspired by the hardening process of butterfly wings, this study proposed a dopamine-metal-phenol strategy to modify decellularized porcine pericardium (DPP). This is a strategy to make dopamine (DA) coordinate trivalent metal chromium ions (Cr(III)) with antiplatelets (PLTs) and anti-inflammatory properties, and then cross-link it with tea polyphenols (TP) to generate a valve scaffold that is mechanically comparable to glutaraldehyde-cross-linked scaffolds but avoids the cytotoxicity of aldehyde and presents better biocompatibility, hemocompatibility, anticalcification, and anti-inflammatory response properties.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Aortic Disease and Treatment Approaches · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China

Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery, Wuhan 430071, China

Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease, Wuhan 430071, China

Funding

National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.1038/s41569-021-00570-z10.1038/s41569-021-00570-z ↗
2. 10.1038/s41569-020-0422-810.1038/s41569-020-0422-8 ↗
3. 10.1016/j.biomaterials.2007.02.01710.1016/j.biomaterials.2007.02.017 ↗
4. 10.1093/rb/rbu00910.1093/rb/rbu009 ↗
5. 10.1016/S0142-9612(00)00148-410.1016/S0142-9612(00)00148-4 ↗
6. 10.1177/088532822098406610.1177/0885328220984066 ↗
7. 10.1016/j.msec.2021.11233710.1016/j.msec.2021.112337 ↗
8. 10.1111/joim.1260510.1111/joim.12605 ↗
9. 10.1093/eurheartj/ehac03710.1093/eurheartj/ehac037 ↗
10. 10.1016/0142-9612(96)82721-910.1016/0142-9612(96)82721-9 ↗
11. 10.1021/acs.biomac.8b0007710.1021/acs.biomac.8b00077 ↗
12. 10.3389/fphar.2022.90980110.3389/fphar.2022.909801 ↗
13. 10.1172/JCI5964310.1172/JCI59643 ↗
14. 10.1038/s41551-024-01221-710.1038/s41551-024-01221-7 ↗
15. 10.1210/me.2005-025510.1210/me.2005-0255 ↗
16. 10.1016/j.envres.2019.10895810.1016/j.envres.2019.108958 ↗
17. 10.1016/j.heliyon.2023.e1982610.1016/j.heliyon.2023.e19826 ↗
18. 10.1007/s12011-019-01783-710.1007/s12011-019-01783-7 ↗
19. 10.2337/diacare.27.11.274110.2337/diacare.27.11.2741 ↗
20. 10.1016/j.ctcp.2020.10129110.1016/j.ctcp.2020.101291 ↗
21. 10.1016/j.freeradbiomed.2004.08.00310.1016/j.freeradbiomed.2004.08.003 ↗
22. 10.1024/0300-9831/a00070610.1024/0300-9831/a000706 ↗
23. 10.1182/blood.V35.5.659.65910.1182/blood.V35.5.659.659 ↗
24. 10.1002/adhm.20170091810.1002/adhm.201700918 ↗
25. 10.1016/j.biomaterials.2006.02.01410.1016/j.biomaterials.2006.02.014 ↗
26. 10.1055/s-0039-169791810.1055/s-0039-1697918 ↗
27. 10.1002/adfm.20221126710.1002/adfm.202211267 ↗
28. 10.1016/j.bioactmat.2021.10.00310.1016/j.bioactmat.2021.10.003 ↗
29. 10.1016/j.carbpol.2022.12004710.1016/j.carbpol.2022.120047 ↗
30. 10.1016/j.carbpol.2020.11759810.1016/j.carbpol.2020.117598 ↗
31. 10.7150/ijbs.887910.7150/ijbs.8879 ↗
32. 10.1161/CIRCRESAHA.123.32361710.1161/CIRCRESAHA.123.323617 ↗
33. 10.1016/j.jtemb.2019.04.01210.1016/j.jtemb.2019.04.012 ↗
34. 10.1007/s40495-016-0061-210.1007/s40495-016-0061-2 ↗
35. Institute of Medicine (US) Panel on Micronutrients · 2001
36. 10.1093/advances/nmx02110.1093/advances/nmx021 ↗
37. 10.3390/nu1413268710.3390/nu14132687 ↗
38. 10.3390/bioengineering601001710.3390/bioengineering6010017 ↗
39. 10.1016/j.actbio.2016.05.02610.1016/j.actbio.2016.05.026 ↗
40. 10.1021/nn504077c10.1021/nn504077c ↗
41. Hafiz I. · J. Biol. Regul Homeost Agents · 2018 · 32 · 101
42. 10.3390/molecules2817640310.3390/molecules28176403 ↗
43. 10.1016/j.biomaterials.2014.03.07810.1016/j.biomaterials.2014.03.078 ↗
44. 10.1016/j.biomaterials.2018.08.06310.1016/j.biomaterials.2018.08.063 ↗
45. 10.1016/j.actbio.2012.10.02510.1016/j.actbio.2012.10.025 ↗
46. 10.1089/ten.tea.2008.026310.1089/ten.tea.2008.0263 ↗
47. 10.1007/s13239-010-0014-610.1007/s13239-010-0014-6 ↗
48. 10.1021/acsami.4c0317110.1021/acsami.4c03171 ↗
49. 10.1002/adhm.20230373710.1002/adhm.202303737 ↗